These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5879805)

  • 21. Measles outbreak in the Republic of the Marshall Islands, 2003.
    Hyde TB; Dayan GH; Langidrik JR; Nandy R; Edwards R; Briand K; Konelios M; Marin M; Nguyen HQ; Khalifah AP; O'leary MJ; Williams NJ; Bellini WJ; Bi D; Brown CJ; Seward JF; Papania MJ
    Int J Epidemiol; 2006 Apr; 35(2):299-306. PubMed ID: 16299123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination.
    Bertley FM; Ibrahim SA; Libman M; Ward BJ
    Vaccine; 2004 Dec; 23(4):444-9. PubMed ID: 15530692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experiences with the live measles vaccine].
    Vivell O; Lips G
    Arch Kinderheilkd; 1967; 176(2):156-63. PubMed ID: 5592896
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunity after measles vaccination].
    Nöbel B
    Z Gesamte Hyg; 1980; 26(12):885-7. PubMed ID: 7234003
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
    Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
    Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
    [No Abstract]   [Full Text] [Related]  

  • 26. [Febrile exanthema following measles vaccination--risk of recurrence in the 2d measles vaccination?].
    Wiersbitzky S; Bruns R
    Kinderarztl Prax; 1991 Dec; 59(12):384-5. PubMed ID: 1774855
    [No Abstract]   [Full Text] [Related]  

  • 27. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
    Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
    Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experience with vaccination against measles in Czech regions].
    Adam E; Domoráková E; Kratochvílová M; Burian V; Janotová J; Drevo M; Verhun V; Doubková S; Hartl J
    Cesk Pediatr; 1970 Sep; 25(9):438-40. PubMed ID: 5455607
    [No Abstract]   [Full Text] [Related]  

  • 29. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The perilous path to a better measles vaccine.
    Minor PD
    CVI Forum; 1992 Oct; (2):8-10. PubMed ID: 12321775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience with the production, control and use of live measles vaccine L-16 SSW].
    Shtarke G; Khlinak R
    Vopr Virusol; 1968; 13(6):724-9. PubMed ID: 5753361
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
    Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
    [No Abstract]   [Full Text] [Related]  

  • 33. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of antibody response following measles vaccination.
    Med J Aust; 1968 Mar; 1(12):489-91. PubMed ID: 5647361
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of measles and measles vaccines on diphtherial immunity].
    Dumkina NV
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():257-60. PubMed ID: 5860946
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical reactogenicity and immunogenicity of five live measles vaccine strains.
    Chin Med J (Engl); 1981 Apr; 94(4):201-6. PubMed ID: 6790234
    [No Abstract]   [Full Text] [Related]  

  • 37. [Exanthema with high fever and cerebral seizure susceptibility after mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Mentel R
    Kinderarztl Prax; 1993 Aug; 61(6):227-8. PubMed ID: 8105135
    [No Abstract]   [Full Text] [Related]  

  • 38. Maternal antibody inhibits both cellular and humoral immunity in response to measles vaccination at birth.
    Premenko-Lanier M; Hodge G; Rota P; Tamin A; Bellini W; McChesney M
    Virology; 2006 Jul; 350(2):429-32. PubMed ID: 16569419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Measles immunization and its problems].
    Kökkaya A
    Mikrobiyol Bul; 1982 Jan; 16(1):66-70. PubMed ID: 7144618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atopic eczema with generalized lymph node swelling and deficient antibody formation despite repeat vaccination with live vaccines (measles, mumps)--atypical vaccination reaction, vaccination damage or vaccination failure?].
    Wiersbitzky S; Peters A; Bruns R; Pambor M
    Kinderarztl Prax; 1993 Feb; 61(1):34-6. PubMed ID: 8464197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.